DK3103046T3 - Biomarkør-signaturfremgangsmåde og apparater og kits deraf - Google Patents

Biomarkør-signaturfremgangsmåde og apparater og kits deraf Download PDF

Info

Publication number
DK3103046T3
DK3103046T3 DK15746053.6T DK15746053T DK3103046T3 DK 3103046 T3 DK3103046 T3 DK 3103046T3 DK 15746053 T DK15746053 T DK 15746053T DK 3103046 T3 DK3103046 T3 DK 3103046T3
Authority
DK
Denmark
Prior art keywords
kits
devices
biomarker signature
signature procedure
procedure
Prior art date
Application number
DK15746053.6T
Other languages
English (en)
Inventor
Richard Bruce Brandon
Leo Charles Mchugh
Original Assignee
Immunexpress Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014900363A external-priority patent/AU2014900363A0/en
Application filed by Immunexpress Pty Ltd filed Critical Immunexpress Pty Ltd
Application granted granted Critical
Publication of DK3103046T3 publication Critical patent/DK3103046T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Data Mining & Analysis (AREA)
DK15746053.6T 2014-02-06 2015-02-06 Biomarkør-signaturfremgangsmåde og apparater og kits deraf DK3103046T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014900363A AU2014900363A0 (en) 2014-02-06 Biomarker Signature Method, and Apparatus and Kits Therefor
PCT/AU2015/050043 WO2015117204A1 (en) 2014-02-06 2015-02-06 Biomarker signature method, and apparatus and kits therefor

Publications (1)

Publication Number Publication Date
DK3103046T3 true DK3103046T3 (da) 2020-06-02

Family

ID=53754326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15746053.6T DK3103046T3 (da) 2014-02-06 2015-02-06 Biomarkør-signaturfremgangsmåde og apparater og kits deraf

Country Status (8)

Country Link
US (4) US20150218640A1 (da)
EP (1) EP3103046B1 (da)
JP (1) JP2017512304A (da)
CN (1) CN105981026A (da)
AU (1) AU2015213486B2 (da)
CA (1) CA2930925A1 (da)
DK (1) DK3103046T3 (da)
WO (1) WO2015117204A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
CA2930925A1 (en) 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
DK3304093T3 (da) 2015-05-28 2024-02-12 Immunexpress Pty Ltd Validering af biomarkørmåling
AU2016331663B2 (en) * 2015-09-30 2022-04-07 Immunexpress Pty Ltd Pathogen biomarkers and uses therefor
EP3371324B1 (en) * 2015-11-06 2021-08-18 ImmuneXpress Pty Ltd Viral biomarkers and uses therefor
CN106701900B (zh) * 2015-11-16 2020-03-20 上海市东方医院 长链非编码rna herc2p3基因及其在胃癌中的用途
CN105256063B (zh) * 2015-12-01 2019-03-01 北京泱深生物信息技术有限公司 肿瘤标志物dmbx1及其应用
EP3394291B1 (en) 2015-12-24 2021-10-06 Immunexpress Pty Ltd Triage biomarkers and uses therefor
CN105506172B (zh) * 2016-03-01 2019-04-09 北京泱深生物信息技术有限公司 含检测gfod2的骨质疏松血液诊断试剂及其应用
WO2017165693A1 (en) * 2016-03-23 2017-09-28 Peach Intellihealth, Inc. Use of clinical parameters for the prediction of sirs
EP3504344A1 (en) * 2016-08-24 2019-07-03 Immunexpress Pty Ltd Systemic inflammatory and pathogen biomarkers and uses therefor
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome
EP3538667B1 (en) 2016-11-08 2024-03-20 Qvella Corporation Methods of performing nucleic acid stabilization and separation
CN106755343A (zh) * 2016-12-01 2017-05-31 北京致成生物医学科技有限公司 胰腺癌预后诊断分子标记物
US11435370B2 (en) * 2017-01-16 2022-09-06 Shimadzu Corporation Data analying device and program for data analysis
US11286525B2 (en) 2017-01-17 2022-03-29 Duke University Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
CN108341862B (zh) * 2017-01-24 2021-04-02 上海交通大学医学院附属仁济医院 一种多肽及其应用
CN106947808B (zh) * 2017-03-10 2020-07-24 北京赛尔得生物技术有限公司 Tmem104基因在制备治疗椎间盘退行性疾病药物中的应用
CN107133475B (zh) * 2017-05-10 2020-09-29 浙江省立同德医院 一种中药注射剂不良反应高危患者模式识别方法
WO2018231771A1 (en) 2017-06-13 2018-12-20 Bostongene Corporation Systems and methods for generating, visualizing and classifying molecular functional profiles
WO2019095064A1 (en) * 2017-11-15 2019-05-23 UNIVERSITé LAVAL Use of srsf3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
CN108753834B (zh) * 2018-05-28 2021-11-23 上海海洋大学 ddx27基因缺失斑马鱼突变体的制备方法
US20210104321A1 (en) * 2018-11-15 2021-04-08 Ampel Biosolutions, Llc Machine learning disease prediction and treatment prioritization
EP3898692A4 (en) 2018-12-19 2022-10-19 The Trustees of the University of Pennsylvania USE OF INACTIVATED CD2/5/7 ANTI-CD2/5/7 CHIMERIC ANTIGEN RECEPTOR T LYMPHOCYTES AGAINST T LYMPHOCYTE LYMPHOCYTE LYMPHOMAS AND LEUKEMIAS
CN111443065A (zh) * 2019-01-17 2020-07-24 四川大学华西医院 一种肺癌的筛查试剂盒
CN109762911B (zh) * 2019-02-21 2020-12-01 华中农业大学 Ptprj基因作为猪免疫相关性状的分子标记及其应用
EP3942569A4 (en) * 2019-03-19 2022-12-07 Optina Diagnostics, Inc. METHOD AND SYSTEM FOR IDENTIFYING SUBJECTS POTENTIALLY AFFECTED BY A HEALTH PROBLEM
CN112409376A (zh) * 2019-08-20 2021-02-26 华东师范大学 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用
CN110567861B (zh) * 2019-09-09 2021-12-21 浙江普罗亭健康科技有限公司 基于质谱流式检测技术筛查具有免疫原性抗原肽的试剂盒及检测方法
CN110558279B (zh) * 2019-09-16 2021-11-16 南方科技大学 一种药物筛选模型、药物筛选方法及其应用
CN110687285B (zh) * 2019-10-29 2023-03-21 安徽医科大学 诊断试剂盒及mak16在制备***性红斑狼疮早期诊断试剂中的应用
CN110791523B (zh) * 2019-12-13 2022-05-10 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
CN111276248B (zh) * 2020-01-20 2023-09-12 苏州帕诺米克生物医药科技有限公司 状态确定***和电子设备
CN114317745B (zh) * 2020-03-30 2022-06-07 中国医学科学院肿瘤医院 外泌体arpc5、eri3等在肺癌诊断中的应用
CN112553322B (zh) * 2020-12-25 2022-07-05 深圳市人民医院 一种骨质疏松诊断标志物及其应用
CN113125757B (zh) * 2021-04-22 2022-10-28 石河子大学 一种用于母猪早期妊娠诊断的蛋白生物标志物及其用于母猪早期妊娠检测的方法
EP4326877A1 (en) * 2021-04-23 2024-02-28 Alnylam Pharmaceuticals, Inc. Irna compositions and methods for silencing chitinase 3-like protein 1/ykl-40 (chi3l1/ykl-40) protein
JP2024520049A (ja) * 2021-05-25 2024-05-21 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア 敗血症のエンドタイプおよび／または重症度の診断
CN114875144A (zh) * 2022-04-02 2022-08-09 及智(苏州)医学技术有限公司 用于评估肿瘤ibc疗法的疗效的生物标志物、***、方法及试剂盒
WO2023224913A1 (en) * 2022-05-16 2023-11-23 Cz Biohub Sf, Llc Integrated host-microbe metagenomics of cell-free nucleic acid for sepsis diagnosis

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980488A (fi) 1998-03-04 1999-09-05 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US20070134261A1 (en) 2001-12-03 2007-06-14 Hancock Robert E Effectors of innate immunity
JP2004041121A (ja) * 2002-07-12 2004-02-12 Hitachi Ltd アレルギー解析方法及びシステム
BR0316231A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo e para isolar um biomarcador, perfil biomarcador r kit
CA2505785A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
EP1611255A2 (de) 2003-04-02 2006-01-04 SIRS-Lab GmbH Verfahren zur erkennung akuter generalisierter entzündlicher zustände (sirs), sepsis, sepsis ähnlichen zuständen und systemischen infektionen
KR20060031809A (ko) 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
EP1673465A4 (en) * 2003-09-29 2008-04-30 Biosite Inc PROCESS AND COMPOSITIONS FOR SEPSIS DIAGNOSIS
DE102004009952B4 (de) 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis
WO2006042192A2 (en) 2004-10-06 2006-04-20 The Brigham And Womens's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
AU2006236588A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
AU2006259583A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
DE102005050933A1 (de) 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
EP1951899B1 (en) 2005-11-25 2010-06-30 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
US8014957B2 (en) 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
US20070255113A1 (en) 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US8450057B2 (en) 2006-08-14 2013-05-28 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
CA2696947A1 (en) * 2007-09-07 2009-03-12 Universite Libre De Bruxelles Methods and tools for prognosis of cancer in er- patients
US20100285001A1 (en) * 2007-10-02 2010-11-11 University Of Rochester Method and Compositions Related to Synergistic Responses to Oncogenic Mutations
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
DE102008000715B9 (de) 2008-03-17 2013-01-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen
JP2009229340A (ja) * 2008-03-25 2009-10-08 Sysmex Corp 全身性炎症反応症候群の重症度に関する情報を生成する方法及び装置
AU2010204741B2 (en) * 2009-01-14 2016-01-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ratio based biomarkers and methods of use thereof
SG176619A1 (en) 2009-07-10 2012-01-30 Transgene Sa Biomarker for selecting patients and related methods
US20110076685A1 (en) 2009-09-23 2011-03-31 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
US20110312521A1 (en) 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
EP2643483A4 (en) * 2010-11-26 2014-04-30 Immunexpress Pty Ltd DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR
US20130084343A1 (en) 2011-09-16 2013-04-04 Cepheid Methods of detecting sepsis
US20150315643A1 (en) 2012-12-13 2015-11-05 Baylor Research Institute Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
CA2930925A1 (en) 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor

Also Published As

Publication number Publication date
AU2015213486A1 (en) 2016-06-02
EP3103046A4 (en) 2017-08-23
US20150259746A1 (en) 2015-09-17
US10865447B2 (en) 2020-12-15
US20220325348A1 (en) 2022-10-13
AU2015213486B2 (en) 2020-10-22
AU2015213486A9 (en) 2016-07-07
CN105981026A (zh) 2016-09-28
WO2015117204A1 (en) 2015-08-13
WO2015117204A9 (en) 2016-06-23
JP2017512304A (ja) 2017-05-18
US20150218640A1 (en) 2015-08-06
EP3103046A1 (en) 2016-12-14
US20170191129A1 (en) 2017-07-06
CA2930925A1 (en) 2015-08-13
EP3103046B1 (en) 2020-03-25
US11047010B2 (en) 2021-06-29

Similar Documents

Publication Publication Date Title
DK3103046T3 (da) Biomarkør-signaturfremgangsmåde og apparater og kits deraf
DK3205650T3 (da) Egfr-hæmmer og fremstilling og anvendelse deraf
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3333191T3 (da) Anti-C10ORF54-antistoffer og anvendelser deraf
DK3212189T3 (da) Substituerede chromaner og fremgangsmåde til anvendelse deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3215601T3 (da) Fremgangsmåder til transduktion og celleforarbejdning
DK3156503T3 (da) Mavecancer-biomarkør og detektionsfremgangsmåde
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3172213T3 (da) Makrocykliske kinasehæmmere og anvendelser deraf
DK3319611T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3159406T3 (da) Kit eller indretning til påvisning af øsufagus-cancer og fremgangsmåde til påvisning
DK3319612T3 (da) Oxysteroler og fremgansmåder til anvendelse derfor
DK3158345T3 (da) Teststikanordning og relaterede fremgangsmåder
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
DK3101760T3 (da) Opladningsfremgangsmåde og system
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3233105T3 (da) Hidtil ukendt kombination og anvendelse
DK3212659T3 (da) Midler og fremgangsmåder til stedspecifik funktionalisering af polypeptider
DK3516160T3 (da) Brøndanordning og tilhørende fremgangsmåder
DK3146320T3 (da) Detekteringsanordning og fremgangsmåde